Vaccine Development

Top-level science through the eyes of an expert.The sixth Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Laurent Reber, Laboratory Director at the Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy, France) and Principal Investigator at the French National Institute of Health and Medical Research (INSERM, France). In this webinar,Read more

Why testing & mitigating Injection Site Reactions is critical during drugs/vaccines development? Injection site reactions (ISR) are a common occurrence when a person receives an injection in the skin, such as a vaccine or self-administered biologics.These reactions occur due to the activation of the immune system at the injection site. When a foreign substance, such as a vaccine or medication,Read more

Top-level science through the eyes of an expert.The fourth Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Behazine Combadière, PhD, the Global Head of Preclinical and Human Immunology at the R&D Vaccines Department of Sanofi. In this webinar, Dr. Combadière will focus on the science behind epidermal & dermal vaccinationRead more

Before proceeding to clinical trials in humans, today’s scientists study drug efficacy and toxicity in animals. Even though animal studies clearly raise ethical questions, it is considered even more unethical to conduct studies directly on humans without prior testing. Genoskin provides a unique alternative to animal testing and to human trials, using real, immunocompetent human skin. Why human skin isRead more

Genoskin COVID-19 research preferred access program On Friday, March 13th 2020, Genoskin launched a preferred access program for all research teams actively developing therapeutic and vaccine technologies for the COVID-19 pandemic. The World Health Organization (WHO) officially declared on March 11th, the outbreak of COVID-19 a pandemic. The disease caused by SARS-CoV-2 has spread globally. Over 130,000 individuals are affected so

Read more